91 related articles for article (PubMed ID: 15870169)
1. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.
Meredith EJ; Holder MJ; Chamba A; Challa A; Drake-Lee A; Bunce CM; Drayson MT; Pilkington G; Blakely RD; Dyer MJ; Barnes NM; Gordon J
FASEB J; 2005 Jul; 19(9):1187-9. PubMed ID: 15870169
[TBL] [Abstract][Full Text] [Related]
2. SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies.
Chamba A; Holder MJ; Jarrett RF; Shield L; Toellner KM; Drayson MT; Barnes NM; Gordon J
Leuk Res; 2010 Aug; 34(8):1103-6. PubMed ID: 20363025
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.
Hayat S; Williams RJ; Rattray M
J Psychopharmacol; 2006 Mar; 20(2):257-63. PubMed ID: 16510483
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agents.
McNamara YM; Cloonan SM; Knox AJ; Keating JJ; Butler SG; Peters GH; Meegan MJ; Williams DC
Bioorg Med Chem; 2011 Feb; 19(3):1328-48. PubMed ID: 21227702
[TBL] [Abstract][Full Text] [Related]
5. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
Jones DC; Lau SS; Monks TJ
J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.
Cloonan SM; Keating JJ; Butler SG; Knox AJ; Jørgensen AM; Peters GH; Rai D; Corrigan D; Lloyd DG; Williams DC; Meegan MJ
Eur J Med Chem; 2009 Dec; 44(12):4862-88. PubMed ID: 19717215
[TBL] [Abstract][Full Text] [Related]
7. Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethamphetamine (MDMA) under acidic conditions.
Yamauchi Y; Izumi T; Unemura K; Uenishi Y; Nakagawa T; Kaneko S
Neurosci Lett; 2007 Nov; 428(2-3):72-6. PubMed ID: 17949903
[TBL] [Abstract][Full Text] [Related]
8. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
9. Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.
Jazirehi AR; Vega MI; Bonavida B
Cancer Res; 2007 Feb; 67(3):1270-81. PubMed ID: 17283164
[TBL] [Abstract][Full Text] [Related]
10. The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters.
Cloonan SM; Drozgowska A; Fayne D; Williams DC
Leuk Lymphoma; 2010 Mar; 51(3):523-39. PubMed ID: 20141432
[TBL] [Abstract][Full Text] [Related]
11. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
Schuldiner S; Steiner-Mordoch S; Yelin R; Wall SC; Rudnick G
Mol Pharmacol; 1993 Dec; 44(6):1227-31. PubMed ID: 7903417
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide-induced apoptosis of human malignant lymphoma cell lines and its mechanisms.
Lu D; Bai XC; Gui L; Li M; Zheng WS; Han XQ; Luo SQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):997-1001. PubMed ID: 14559676
[TBL] [Abstract][Full Text] [Related]
14. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells.
Launay JM; Schneider B; Loric S; Da Prada M; Kellermann O
FASEB J; 2006 Sep; 20(11):1843-54. PubMed ID: 16940156
[TBL] [Abstract][Full Text] [Related]
16. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
17. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.
Barker EL; Kimmel HL; Blakely RD
Mol Pharmacol; 1994 Nov; 46(5):799-807. PubMed ID: 7969065
[TBL] [Abstract][Full Text] [Related]
18. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
Walker A; Taylor ST; Hickman JA; Dive C
Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
[TBL] [Abstract][Full Text] [Related]
20. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
